Production process analysis: a review of the device history record confirmed that the device was manufactured and tested according to relevant procedures, and shipped according to manufacturer's specifications.User (surgeon and patient) information analysis: on 30-jan-2023 apifix was notified that the surgeon who performed index surgery on patient (b)(6) was concerned about a change in the patient's t12 screw position since the index procedure ((b)(6) 2023).The surgeon's concern was about a slightly lateral trajectory on the initial t12 screw placement.On (b)(6) 2023 the patient underwent a revision surgery during which the initial screw (6.5x40 mm) was replaced with a larger screw (7.0x45 mm) with more medial trajectory.A shorter mid-c 115 was used in place of the explanted mid-c 125.Risk assessment: reoperation events are a known risk that was assessed and recorded by the product risk management file.The risk of screw pullout has been assessed and found to be acceptable the current screw pullout rate due to any reason is in line with the rate reported in the literature for this type of complication as described in the company's cer (clinical evaluation report).The risk has been quantified, characterized, and documented as acceptable within a full risk assessment.Apifix is closing this complaint, but will continue to monitor this 'failure mode'; complaint trending will continue to monitor per post marketing surveillance procedure.If any further relevant information is identified, the complaint file will be reopened and a supplemental medwatch will be filed.
|